​

PMV Pharmaceuticals Ownership | Who Owns PMV Pharmaceuticals?


OverviewForecastFinancialsChart

PMV Pharmaceuticals Ownership Summary


PMV Pharmaceuticals is owned by 105.19% institutional investors, 2.36% insiders. Bml capital management is the largest institutional shareholder, holding 13.73% of PMVP shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 3.16% of its assets in PMV Pharmaceuticals shares.

PMVP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPMV Pharmaceuticals105.19%2.36%-7.55%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bml capital management7.33M13.73%$12.24M
Tang capital management4.25M7.97%$5.26M
Vanguard capital management3.08M5.78%$5.15M
Sio capital management3.08M5.77%$3.81M
Arrowmark colorado2.87M5.39%$3.56M
Euclidean capital2.63M4.93%$3.26M
Eversept partners, lp2.35M4.41%$2.91M
Acadian asset management2.29M4.28%$3.81M
Vanguard group2.17M4.10%$2.71M
Two sigma investments, lp1.88M3.54%$2.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management7.33M6.52%$12.24M
Euclidean capital2.63M0.83%$3.26M
Aldebaran capital489.54K0.59%$817.53K
Sio capital management3.08M0.55%$3.81M
Tang capital management4.25M0.27%$5.26M
Verdad advisers, lp180.16K0.25%$223.40K
Eversept partners, lp2.35M0.15%$2.91M
Affinity asset advisors1.75M0.12%$2.92M
Arrowmark colorado2.87M0.09%$3.56M
Rangeley capital66.85K0.08%$82.89K

Top Buyers

HolderShares% AssetsChange
Eversept partners, lp2.35M0.15%2.35M
Bml capital management7.33M6.52%2.00M
Adage capital partners gp1.86M0.00%1.86M
Affinity asset advisors1.75M0.12%1.75M
Two sigma investments, lp1.88M0.00%1.18M

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---4.98M
Pfm health sciences, lp---3.30M
Alkeon capital management---2.34M
Blackrock1.16M--1.95M
Bank of america corp /de/340.39K--1.03M

New Positions

HolderShares% AssetsChangeValue
Eversept partners, lp2.35M0.15%2.35M$2.91M
Adage capital partners gp1.86M0.00%1.86M$2.31M
Affinity asset advisors1.75M0.12%1.75M$2.92M
Verdad advisers, lp180.16K0.25%180.16K$223.40K
Empowered funds75.58K0.00%75.58K$126.21K

Sold Out

HolderChange
Sbi securities-1.00
Nelson, van denburg & campbell wealth management group-8.00
Nisa investment advisors-105.00
Raymond james financial-200.00
Avion wealth-299.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202664-1.54%56,156,93763.81%1052.55%3182.35%11-50.00%
Jun 30, 202665-7.14%34,280,762-7.25%641.34%18-43.75%2110.53%
Mar 31, 202629-53.97%12,465,938-66.69%230.47%15-53.13%8-52.94%
Dec 31, 202528-55.56%14,874,571-60.33%280.54%13-61.76%10-33.33%
Sep 30, 20256022.45%37,409,48511.18%711.72%3193.75%15-21.05%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest2.38M3.16%897.44K
Vanguard US Total Market Shares ETF1.52M2.94%-
Vanguard Total Stock Mkt Idx Inv1.49M2.79%-
Vanguard Morn Total Stk Mkt Idx Investor1.49M2.79%-
ACAP Strategic A1.15M2.16%-
ArrowMark Small Cap Gro1.06M1.98%-22.21K
Meridian Small Cap Growth Legacy910.87K1.21%-145.84K
SQUAD Aguja Opportunities I570.00K1.08%-
Vanguard Institutional Extnd Mkt Idx Tr452.36K0.85%-
Bridgeway Ultra-Small Company331.45K0.62%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 23, 2025ORBIMED ADVISORS LLC-Sell$1.52M
Sep 10, 2025ORBIMED ADVISORS LLC-Sell$900.00K
Jul 01, 2025Ticktin Robert General Counsel & COOSell$24.65K
Jul 01, 2025Jalota Deepika Chief Development OfficerSell$35.20K
Jul 01, 2025Carulli Michael Chief Financial OfficerSell$30.08K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q4-1
2025 Q3-5
2025 Q2--

PMVP Ownership FAQ


Who Owns PMV Pharmaceuticals?

PMV Pharmaceuticals shareholders are primarily institutional investors at 105.19%, followed by 2.36% insiders and -7.55% retail investors. The average institutional ownership in PMV Pharmaceuticals's industry, Biotech Stocks , is 181.71%, which PMV Pharmaceuticals falls below.

Who owns the most shares of PMV Pharmaceuticals?

PMV Pharmaceuticals’s largest shareholders are Bml capital management (7.33M shares, 13.73%), Tang capital management (4.25M shares, 7.97%), and Vanguard capital management (3.08M shares, 5.78%). Together, they hold 27.47% of PMV Pharmaceuticals’s total shares outstanding.

Does Blackrock own PMV Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of PMV Pharmaceuticals.

Who is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 6.52% of its assets in 7.33M PMV Pharmaceuticals shares, valued at 12.24M$.

Who is the top mutual fund holder of PMV Pharmaceuticals shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of PMV Pharmaceuticals shares, with 3.16% of its total shares outstanding invested in 2.38M PMV Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools